Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Recurrent small intestinal ileus secondary to valsartan treatment.

Saadi T, Brun R, Chowers Y, Baruch Y, Waterman M.

J Clin Gastroenterol. 2014 May-Jun;48(5):462-3. doi: 10.1097/MCG.0000000000000045. No abstract available.

PMID:
24296424
2.

Lithium intoxication after valsartan treatment.

Su YP, Chang CJ, Hwang TJ.

Psychiatry Clin Neurosci. 2007 Apr;61(2):204. No abstract available.

3.

[Acute renal failure and hypertension].

Bellido D, Sánchez de la Nieta MD, Vozmediano C, Oteros R, Zarca MA, Nieto J, Rivera F.

Nefrologia. 2005;25(5):563-7. Spanish.

4.

Valsartan inefficacy or ill-effects of concomitant medications!

Bangalore S, Messerli FH.

Am J Cardiol. 2010 Aug 15;106(4):602-3. doi: 10.1016/j.amjcard.2010.06.005. No abstract available.

PMID:
20691326
5.

Angiotensin receptor blockers and myocardial infarction.

Verma S, Strauss M.

BMJ. 2004 Nov 27;329(7477):1248-9. No abstract available.

6.

Second study on valsartan is threatened with retraction over alleged data manipulation.

Mahony C.

BMJ. 2013 Aug 5;347:f4920. doi: 10.1136/bmj.f4920. No abstract available.

PMID:
23918698
7.

Aliskiren/valsartan (Valturna) for hypertension.

[No authors listed]

Med Lett Drugs Ther. 2009 Nov 30;51(1326):94-5. Review. No abstract available.

PMID:
20224524
8.

Valsartan-induced drug eruption followed by CD30+ pseudolymphomatous eruption.

Sawada Y, Yoshiki R, Kawakami C, Fukamachi S, Sugita K, Nakamura M, Tokura Y.

Acta Derm Venereol. 2010 Sep;90(5):521-2. doi: 10.2340/00015555-0695. No abstract available.

9.

[New effective dosage of valsartan. High dosage--effective against high blood pressure].

[No authors listed]

MMW Fortschr Med. 2007 Nov 15;149(46):52-3. German. No abstract available.

PMID:
18069195
10.

Effect of valsartan on systemic right ventricular function: a double-blind, randomized, placebo-controlled pilot trial.

van der Bom T, Winter MM, Bouma BJ, Groenink M, Vliegen HW, Pieper PG, van Dijk AP, Sieswerda GT, Roos-Hesselink JW, Zwinderman AH, Mulder BJ.

Circulation. 2013 Jan 22;127(3):322-30. doi: 10.1161/CIRCULATIONAHA.112.135392. Epub 2012 Dec 17.

11.

Exanthematous drug eruption due to valsartan.

Ozturk G, Turk BG, Senturk B, Turkmen M, Kandiloglu G.

Cutan Ocul Toxicol. 2012 Dec;31(4):335-7. doi: 10.3109/15569527.2011.647179. Epub 2012 Jan 18.

PMID:
22257082
12.
13.

Valsartan-induced angioedema in a patient on angiotensin-converting enzyme inhibitor for years: case report and literature review.

Kalra A, Cooley C, Palaniswamy C, Kalra A, Zanotti-Cavazzoni SL.

Am J Ther. 2012 Nov;19(6):e189-92. doi: 10.1097/MJT.0b013e3181f28f84. Review.

PMID:
20838200
14.

Angiotensin receptor blockers and myocardial infarction: the importance of dosage.

Sarzani R, Dessì-Fulgheri P.

J Hypertens. 2006 Aug;24(8):1679-81; author reply 1681-2. No abstract available.

PMID:
16877973
15.

[A case of valsartan-induced pneumonitis with marked elevation of serum KL-6].

Takakura A, Kubota M, Otani S, Katono K, Yamamoto M, Masuda N.

Nihon Kokyuki Gakkai Zasshi. 2011 Jul;49(7):523-7. Japanese.

PMID:
21842690
16.

[AT(1) blocker for post-infarct therapy. VALIANT Study].

Hasenfuss G.

Internist (Berl). 2004 Aug;45(8):946-8. German. No abstract available.

PMID:
15252713
17.

Effects of the angiotensin II type 1 receptor antagonist valsartan on the expression of superoxide dismutase in hypertensive patients.

Yang HY, Kao PF, Chen TH, Tomlinson B, Ko WC, Chan P.

J Clin Pharmacol. 2007 Mar;47(3):397-403.

PMID:
17322151
18.

Fetal toxic effects of angiotensin II receptor antagonists: case report and follow-up after birth.

Bos-Thompson MA, Hillaire-Buys D, Muller F, Dechaud H, Mazurier E, Boulot P, Morin D.

Ann Pharmacother. 2005 Jan;39(1):157-61. Epub 2004 Dec 8. Review. Erratum in: Ann Pharmacother. 2005 Feb;39(2):389.

PMID:
15590878
19.

[Fetal toxicity of angiotensin-II-receptor inhibitors. Case report].

Roger N, Popovic I, Madelenat P, Mahieu-Caputo D.

Gynecol Obstet Fertil. 2007 Jun;35(6):556-60. Epub 2007 Jun 1. French.

PMID:
17544313
20.

Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.

Anand IS, Bishu K, Rector TS, Ishani A, Kuskowski MA, Cohn JN.

Circulation. 2009 Oct 20;120(16):1577-84. doi: 10.1161/CIRCULATIONAHA.109.853648. Epub 2009 Oct 5.

Supplemental Content

Support Center